Micropaque

Barium sulfate, the active ingredient in Micropaque, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque imaging of the gastrointestinal tract in patients undergoing diagnostic radiology examinations.

GNH USA supplies Micropaque as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque is used as a gastrointestinal contrast agent in radiographic examinations.

- Barium swallow (upper GI series): enables visualization of the esophagus, stomach and duodenum during X‑ray imaging. - Barium enema (lower GI series): provides contrast for imaging of the colon and rectum. - Other gastrointestinal radiographic examinations: facilitates assessment of intestinal motility and structural abnormalities.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping - Nausea - Constipation - Diarrhea - Mild headache

Serious or Rare Side Effects: - Bowel obstruction - Gastrointestinal perforation - Allergic reaction (rash, itching, swelling) - Aspiration leading to pneumonitis - Severe electrolyte imbalance

Prior to using Micropaque, several safety considerations should be observed.

- Pregnancy: use only if clearly needed, as safety category is unknown. - Renal impairment: assess risk of dehydration before administration. - Bowel obstruction risk: avoid in patients with known strictures or recent surgeries. - Allergy history: inquire about prior reactions to contrast agents. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Micropaque can interact with certain medications and substances; awareness helps minimize risk.

Major Interactions (Avoid): - Potassium iodide preparations: may increase risk of hyperosmolar reactions. - Antacids containing aluminum or magnesium: can alter barium suspension consistency.

Moderate Interactions (Monitor Closely): - Diuretics: monitor for dehydration. - Laxatives: may change barium transit time. - Anticholinergics: may affect gastrointestinal motility.